Fertility treatment in male cancer survivors.
The present study reviews the use of assisted reproductive technology in male cancer survivors and their partners. As antineoplastic treatment with chemotherapy or radiation therapy, has the potential of inducing impairment of spermatogenesis through damage of the germinal epithelium, many male cancer survivors experience difficulties in impregnating their partners after treatment. The impairment can be temporary or permanent. While many cancer survivors regain spermatogenesis months to years after treatment, some become infertile with a-, oligo- or azoospermia. An option to secure the fertility potential of young cancer patients is to cryopreserve semen before cancer treatment for later use. A desired pregnancy may be obtained in couples where the husband has a history of cancer, using assisted reproductive technology with either fresh or cryopreserved/thawed semen. Successful outcomes have been obtained with intrauterine insemination (IUI) as well as in vitro fertilization (IVF) with or without the use of intracytoplasmic sperm injection (ICSI). In conclusion, male cancer survivors and their partners who have failed to obtain a pregnancy naturally within a reasonable time frame after end of treatment should be referred to a fertility clinic.
Schmidt
Kirsten Louise Tryde
KL
The Fertility Clinic, section 4071, University Hospital of Copenhagen, Rigshospitalet, DK-2100 Copenhagen, Denmark. tryde@dadlnet.dk
Carlsen
Elisabeth
E
Andersen
Anders Nyboe
AN
D015925:Cryopreservation; D005298:Fertility; D005307:Fertilization in Vitro; D006801:Humans; D008297:Male; D027724:Reproductive Techniques, Assisted; D012662:Semen Preservation; D017741:Survivors; D013736:Testicular Neoplasms / Q000235:genetics / Q000503:physiopathology* / Q000532:radiotherapy / Q000628:therapy